PL2902038T3 - Nowy sposób leczenia infekcji H. pylori - Google Patents

Nowy sposób leczenia infekcji H. pylori

Info

Publication number: PL2902038T3
Authority: PL; Poland
Prior art keywords: treating; novel method; pylori infections; pylori; infections
Prior art date: 2006-10-19

Application number

PL14003585T

Other languages

English (en)

Inventor

Markus Gerhard

Christian Schmees

Christian Prinz

Original Assignee

Imevax Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-19

Filing date

2007-10-19

Publication date

2018-11-30

2007-10-19 Application filed by Imevax Gmbh filed Critical Imevax Gmbh

2018-11-30 Publication of PL2902038T3 publication Critical patent/PL2902038T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/02—Aminoacyltransferases (2.3.2)
- C12Y203/02002—Gamma-glutamyltransferase (2.3.2.2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Oncology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)

PL14003585T 2006-10-19 2007-10-19 Nowy sposób leczenia infekcji H. pylori PL2902038T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06021936A EP1913955A1 (en)	2006-10-19	2006-10-19	Novel method for treating H.pylori infections
EP14003585.8A EP2902038B1 (en)	2006-10-19	2007-10-19	Novel method for treating H.pylori infections
EP07819171.5A EP2081594B1 (en)	2006-10-19	2007-10-19	Novel method for treating h.pylori infections

Publications (1)

Publication Number	Publication Date
PL2902038T3 true PL2902038T3 (pl)	2018-11-30

Family

ID=37682062

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL07819171T PL2081594T3 (pl)	2006-10-19	2007-10-19	Teobromina w terapii kaszlu
PL14003585T PL2902038T3 (pl)	2006-10-19	2007-10-19	Nowy sposób leczenia infekcji H. pylori

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL07819171T PL2081594T3 (pl)	2006-10-19	2007-10-19	Teobromina w terapii kaszlu

Country Status (15)

Country	Link
US (2)	US9090676B2 (pl)
EP (3)	EP1913955A1 (pl)
JP (2)	JP5989958B2 (pl)
CN (2)	CN101594880B (pl)
AU (1)	AU2007312539A1 (pl)
CA (1)	CA2666859C (pl)
CY (2)	CY1116166T1 (pl)
DK (2)	DK2902038T3 (pl)
ES (2)	ES2527474T3 (pl)
HU (1)	HUE039785T2 (pl)
LT (1)	LT2902038T (pl)
PL (2)	PL2081594T3 (pl)
PT (2)	PT2081594E (pl)
SI (2)	SI2902038T1 (pl)
WO (1)	WO2008046650A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1913955A1 (en) *	2006-10-19	2008-04-23	Gerhard, Markus	Novel method for treating H.pylori infections
JP5904481B2 (ja) *	2011-05-20	2016-04-13	学校法人関西文理総合学園	ピロリ菌の分泌毒素に結合するペプチドおよびその用途
CA2909434A1 (en) *	2013-04-18	2014-10-23	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for inhibiting lymphocyte proliferation in a subject in need thereof
EP3272354A1 (en)	2016-07-20	2018-01-24	Technische Universität München	Agents and methods for the prevention or treatment of h. pylori infections
CN119954904A (zh) *	2025-01-22	2025-05-09	北京润州生物科技有限公司	一种益生菌的制备方法及其在应用于清除口腔中幽门螺杆菌中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR970002255B1 (ko)	1990-06-11	1997-02-26	넥스스타 파아마슈티컬드, 인크.	핵산 리간드
JP2001504448A (ja)	1996-08-30	2001-04-03	フュルステ，イェンス，ペーター	核酸の鏡面対称選択および進化
WO1998017804A2 (en) *	1996-10-17	1998-04-30	Institut Pasteur	A HELICOBACTER ANTIGEN (η-GLUTAMYLTRANSFERASE) AND SEQUENCES ENCODING THE SAME
US20020160456A1 (en) *	1997-06-24	2002-10-31	Harold Kleanthous	Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
DE19742706B4 (de)	1997-09-26	2013-07-25	Pieris Proteolab Ag	Lipocalinmuteine
SE9801288D0 (sv)	1998-04-14	1998-04-14	Astra Ab	Vaccine delivery system and metod of production
SE9801287D0 (sv)	1998-04-14	1998-04-14	Astra Ab	Incorporation of active substances in carrier matrixes
WO2000001825A1 (en) *	1998-07-01	2000-01-13	Institut Pasteur	HELICOBACTER ANTIGEN (η-GLUTAMYLTRANSPEPTIDASE) AND SEQUENCES ENCODING THE SAME
JP2000229997A (ja) *	1999-02-10	2000-08-22	Nissui Pharm Co Ltd	環状ペプチド及びエイズワクチン
US6380217B1 (en) *	1999-03-31	2002-04-30	Millennium Pharmaceuticals, Inc.	Methods for controlling GGT-positive bacteria
AU5937901A (en)	2000-05-03	2001-11-12	Med Immune Inc	Combination therapy of respiratory diseases using antibodies
US20040258699A1 (en) *	2002-02-11	2004-12-23	Bowdish Katherine S.	Immunotherapeutics for biodefense
JP3823268B2 (ja) *	2002-05-30	2006-09-20	独立行政法人科学技術振興機構	ヘリコバクター・ピロリの細胞死誘導剤
DE10239531A1 (de) *	2002-08-23	2004-03-04	Gulbins, Erich, Prof. Dr.	Prophylaxe und Therapie von Infektionserkrankungen
JP2004307477A (ja) *	2003-03-24	2004-11-04	Kobe University	遺伝子導入型ワクチンの中和抗体誘導能を増強する方法、ワクチンの投与方法
JPWO2005075652A1 (ja) *	2004-02-03	2007-10-11	国立大学法人京都大学	グルタリル−７−アミノセファロスポラン酸（ＧＬ−７−ＡＣＡ）アシラーゼ活性が増強された改変γ−グルタミルトランスペプチダーゼ（改変ＧＧＴ）の製造方法
US20070042448A1 (en)	2005-06-02	2007-02-22	Institute Pasteur	Use of enzymes from Helicobacter pylori as therapeutical targets
EP1913955A1 (en) *	2006-10-19	2008-04-23	Gerhard, Markus	Novel method for treating H.pylori infections

2006
- 2006-10-19 EP EP06021936A patent/EP1913955A1/en not_active Withdrawn
2007
- 2007-10-19 AU AU2007312539A patent/AU2007312539A1/en not_active Abandoned
- 2007-10-19 US US12/446,226 patent/US9090676B2/en active Active
- 2007-10-19 SI SI200732046T patent/SI2902038T1/sl unknown
- 2007-10-19 EP EP07819171.5A patent/EP2081594B1/en active Active
- 2007-10-19 WO PCT/EP2007/009106 patent/WO2008046650A1/en not_active Ceased
- 2007-10-19 CN CN200780046762.3A patent/CN101594880B/zh active Active
- 2007-10-19 JP JP2009532733A patent/JP5989958B2/ja active Active
- 2007-10-19 PL PL07819171T patent/PL2081594T3/pl unknown
- 2007-10-19 DK DK14003585.8T patent/DK2902038T3/en active
- 2007-10-19 PT PT78191715T patent/PT2081594E/pt unknown
- 2007-10-19 EP EP14003585.8A patent/EP2902038B1/en active Active
- 2007-10-19 HU HUE14003585A patent/HUE039785T2/hu unknown
- 2007-10-19 DK DK07819171.5T patent/DK2081594T3/en active
- 2007-10-19 CA CA2666859A patent/CA2666859C/en active Active
- 2007-10-19 LT LTEP14003585.8T patent/LT2902038T/lt unknown
- 2007-10-19 SI SI200731586T patent/SI2081594T1/sl unknown
- 2007-10-19 CN CN201610297263.2A patent/CN105879019A/zh active Pending
- 2007-10-19 PL PL14003585T patent/PL2902038T3/pl unknown
- 2007-10-19 ES ES07819171.5T patent/ES2527474T3/es active Active
- 2007-10-19 ES ES14003585.8T patent/ES2682925T3/es active Active
- 2007-10-19 PT PT14003585T patent/PT2902038T/pt unknown
2015
- 2015-01-07 CY CY20151100014T patent/CY1116166T1/el unknown
- 2015-06-16 JP JP2015120784A patent/JP6106213B2/ja active Active
- 2015-06-24 US US14/748,905 patent/US9821048B2/en active Active
2018
- 2018-08-06 CY CY20181100811T patent/CY1120487T1/el unknown

Also Published As

Publication number	Publication date
PL2081594T3 (pl)	2016-01-29
WO2008046650A1 (en)	2008-04-24
CA2666859C (en)	2016-08-16
HUE039785T2 (hu)	2019-02-28
US9090676B2 (en)	2015-07-28
EP2081594B1 (en)	2014-10-22
PT2081594E (pt)	2015-02-05
JP2015214556A (ja)	2015-12-03
ES2527474T3 (es)	2015-01-26
JP5989958B2 (ja)	2016-09-07
EP1913955A1 (en)	2008-04-23
US20100034846A1 (en)	2010-02-11
EP2902038A1 (en)	2015-08-05
HK1212241A1 (en)	2016-06-10
DK2902038T3 (en)	2018-08-13
EP2081594A1 (en)	2009-07-29
CN101594880A (zh)	2009-12-02
PT2902038T (pt)	2018-10-22
SI2902038T1 (sl)	2018-10-30
CY1116166T1 (el)	2017-02-08
EP2902038B1 (en)	2018-06-06
CY1120487T1 (el)	2019-07-10
AU2007312539A1 (en)	2008-04-24
CN105879019A (zh)	2016-08-24
JP2010506575A (ja)	2010-03-04
LT2902038T (lt)	2018-09-10
ES2682925T3 (es)	2018-09-24
US20150306201A1 (en)	2015-10-29
CN101594880B (zh)	2016-08-10
US9821048B2 (en)	2017-11-21
SI2081594T1 (sl)	2015-04-30
DK2081594T3 (en)	2015-01-26
CA2666859A1 (en)	2008-04-24
JP6106213B2 (ja)	2017-03-29

Publication	Publication Date	Title
GB0609366D0 (en)	2006-06-21	Processing method
MX306717B (es)	2013-01-15	Proceso para preparar 2-amino-5-halobenzamidas 3-sustituidas.
EP2097853A4 (en)	2011-06-29	METHOD FOR RECOGNIZING CHARACTERS
EP2028172A4 (en)	2011-05-11	PROCESS FOR PRODUCING 1,3,3,3-TETRAFLUOROPROPENE
GB0601961D0 (en)	2006-03-15	Method
IL183889A0 (en)	2007-10-31	Treatment method
GB0603081D0 (en)	2006-03-29	Method
PL2215031T3 (pl)	2019-09-30	Sposób przetwarzania pucolanów
EP2126688A4 (en)	2011-06-01	METHOD FOR PROCESSING MULTIPLE OPERATIONS
EP1942648A4 (en)	2011-05-25	SUPPORT CONTROL PROCESSING METHOD
GB0610079D0 (en)	2006-06-28	Method & system
EP1909854A4 (en)	2012-02-22	METHOD FOR TREATING CANCER
PT2902038T (pt)	2018-10-22	Novo método para o tratamento de infeções por h. pylori
HUE036822T2 (hu)	2018-08-28	CGNC alkalmazásra H. pylori fertõzésben
GB0605323D0 (en)	2006-04-26	Method
GB0603008D0 (en)	2006-03-29	Method
EP2097408A4 (en)	2010-08-25	IMPROVED PROCESS FOR THE PREPARATION OF EPROSARTAN
GB0604018D0 (en)	2006-04-05	Method
GB0601699D0 (en)	2006-03-08	Method
GB0602986D0 (en)	2006-03-29	Method
ZA200706456B (en)	2008-12-31	Method for treating liquids
PL1842931T3 (pl)	2014-07-31	Sposób obróbki cieplnej
GB0614732D0 (en)	2006-09-06	Bioremediation Method
KR101173574B9 (ko)	2025-01-10	기판처리방법
GB0602958D0 (en)	2006-03-29	Method for treating plants